A Study of the Safety, Tolerance, and Pharmacokinetics of Oral Posaconazole in Immunocompromised Children (P03579)
Status:
Terminated
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this dose-escalation study is to evaluate the pharmacokinetics, safety, and
tolerability of oral posaconazole in immunocompromised children with neutropenia or expected
neutropenia.